Board

Rob ten Hoedt is Executive Vice President & President, Europe, Middle East & Africa (EMEA) and a member of Medtronic’s Executive Committee.  Mr. ten Hoedt has been with Medtronic since 1991 and has over 25 years of experience in the medical device industry. Leading up to this position, he has held several different leadership roles in Medtronic.  He led the CardioVascular business for Europe & Central Asia and the Gastro-Uro business on a global basis before which he ran the wholly-owned Medtronic subsidiary Company, Vitatron.  Prior to Medtronic, he held different positions in medical technology companies such as Arjo Hospital Equipment and Polystan Benelux; and also ran his own Distributor Company for several years.  He is the Chairman of the Board of MedTech Europe, the Association representing the medical technology industry in Europe. Rob holds a degree in Commercial Economy from the H.E.A.O. and a Masters in Marketing from the NIMA Business School in the Netherlands.

Bronwyn is the President of the ImmunoDiagnostics Division of Thermo Fisher Scientific, leading the portfolio innovation and growth of the diagnostic testing business for allergy and autoimmune diseases. Patient access to testing across the globe is limited and her purpose and passion is to address barriers to testing so that patients get the right diagnosis and therapy thereby improving outcomes. She joined the company in 2019 as President of the EMEA region, where she was responsible for aligning the commercial strategies across all divisions to best support customers and leverage the breadth and scale of  Thermo Fisher Scientific. Previously Bronwyn worked at Medtronic where she held the position of Global Vice President/General Manager for Gynaecologic Health. During this time, she led the company’s expansion into the women’s health space and had overall responsibly for the global commercial teams as well as R&D and other support functions. Prior to that she was Vice President, Early Technologies, EMEA where she led a market development program to drive adoption of new therapies in the areas of lung, liver and oesophageal cancer. She also led the M & A  and subsequent integration of several start-ups in the gastrointestinal field into Medtronic. Bronwyn has over twenty years’ experience in the medical device industry having started her career at Johnson & Johnson where she had a range of senior executive roles, across the globe. She is a strong advocate of diversity and inclusion in the workplace and dedicates a significant amount of time to mentoring people from minority backgrounds looking to advance and realise their full potential in the healthcare industry. She is a graduate of Dublin City University with an MBA and a Bachelor of Arts degree in International Marketing & Languages. She speaks Spanish and French. Bronwyn is a mother of two children and the greatest source of joy in her life is spending time with family and friends.

Stuart Silk began his career with Stryker, a leading global medical technology company, in 2008 as Managing Director of France. After assuming roles with increasing responsibility, he was named President of Europe in July 2015 with a focus on accelerating global growth through Stryker’s new Transatlantic Operating Model. From October 2015 to May 2018, his responsibilities were expanded to include EEMEA, Latin America and Canada. Prior to Stryker, Stuart held a variety of leadership and managerial roles in Europe and Latin America at Premier Farnell and CHEP. Stuart is Vice-Chair and Member of the Operations Management Committee of MedTech Europe, a board member of the American Chamber of Commerce in the Netherlands, and a member of the GLG Institute, an invite-only global CEO network. Stuart is a graduate in Management Studies at the University of Leeds.

Dr Meinrad Lugan has an university degree in chemistry (Dipl. Chem.) as well as a PhD in organic chemistry (Dr. rer. nat.), both from the University of Freiburg (Institute for Organic Chemistry and Biochemistry, Prof. Prinzbach). He has held positions as Director of R&D and Director of International Business Development (BUCK System GmbH), Technical Director (BUCK Environmental LLC), Vice President (BUCK CMI Asia), and CEO (MCG Metall-Chemie Goerrig GmbH & Co KG). Since 2000 Dr. Lugan is Member of B. Braun Group Managing Board (Vorstand). He also acts as Chief-Knowledge-Officer. Since 2006 he is Member of the Board of BVMed (Bundesverband Medizintechnologie e. V., Berlin), in 2007 he became Chairman of the Board. Also since 2006 he is Member of the Board of MedTech Europe. He is actively involved in standardization of health care, since 2010 he is Member of the Board of GS1 Germany and GS1 Global. Born in 1964, Dr Lugan is married with one son.

Fernando Davico is DiaSorin’s Corporate Vice President EMEA, APAC and LATAM since 2018. Fernando has extensive experience in the diagnostics and medical device industries having worked more than 19 years for Johnson & Johnson and Hologic prior to joining DiaSorin. He started his career in consulting and later worked in private equity. Fernando is based in Italy and holds a degree in Nuclear Engineering from Instituto Balseiro – Universidad Nacional de Cuyo and an MBA from IDEA, both in his native country Argentina.

Sophie is President International Vision Care Franchise at Alcon. She brings many years of experience in the medical device industry; she joined Alcon from Abbott where she was Divisional Vice President, Diabetes Care. In this position, she had an active role in driving several activities within the diabetes sector group of Medtech Europe. Prior to Abbott, Ms. Dutilloy spent 21 years with Johnson & Johnson, were she held roles of increasing responsibility and scope in consumer products and medical devices. She began her career in Johnson&Johnson consumer marketing in Canada, later transitioning to lead of the UK / Ireland Vision Care business. Ms. Dutilloy then became VP Marketing for the EMEA region and subsequently spent four years in the Global Surgery division holding roles in UK/Ireland, Nordics and EMEA. While leading the UK, she was appointed member of the UK Ministerial Medical Technology Strategy Group, facilitating the discussion between government and the medical technology industry on strategic issues of joint interest. Ms. Dutilloy holds a Bachelor’s degree from IMIP-MBA Institute in Paris France, and a MBA from the Fuqua School of Business Administration at Duke University in Durham, North Carolina.

More than 25 years of experience in the medical technology industry with positions in sales, marketing, P&L management, at local and EMEA level. At ResMed since 2006, currently holding the position of President-Sleep & Respiratory Care. Global responsibility of the Dental Sleep business unit (Narval) since 2016, with manufacturing and R&D based in Lyon, France. Board member of the SNITEM since 2016. Board member at MedTech Europe since 2020.

Dominique Boulet has 25 years of experience in the medical devices and diagnostics industry 20-year tenure with Johnson and Johnson in roles including sales and marketing, business development, strategy and general management. He was most recently President and Chairman of J&J’s medical business in Germany and RVP for the DACH region; In 2016, he transitioned with the Cordis business to Cardinal Health as Vice President Cordis EMEA. With the transformation of Cordis into a standalone company and separating from Cardinal Health, he became President EMEA of Cordis and a member of the executive leadership team in November 2021. He has experience in wound management (AWC business), women’s health (Gynecare), surgery (Ethicon), sterilization (ASP), CV (Cordis), electrophysiology (BW), orthopedics/traum (DePuy), Sports medicine, and many more. He is a Swiss and French citizen, passionate about outdoor sports in the Alps (ski and mountain-bike among others) and sailing.

Graduated from ESSEC and Ottowa University, Pierre began his career as a strategic consultant working for CEOs in various sectors including healthcare within Boston Consulting Group. In 2002, Pierre joined IPSEN group and successfully led strategic projects as Executive VP of Specialty Care Commercial Operations. Pierre Boulud joined bioMérieux and its Executive Committee in 2016 as Corporate VP & Head of ASPAC. Pierre was also in charge of bioMérieux’s portfolio and strategic planning. Since 2020, Pierre leads the Clinical Operations as Executive Vice President. He is also Chief Operating Officer.

Jean-Philippe is a board member of SIDIV, the French IVD trade professional association. He was elected for the first time in 2014, representing first Siemens Healthcare/Healthineers for 6 years, and now Werfen from 2020. He had the opportunity to represent twice his former company at the board of MedTech Europe. He is the General Manager of the French affiliate of Werfen. His role includes developing the Sales and Marketing strategy, overseeing daily business operations, hiring and managing staff, operating budgets. He has more than 22 years of experience in the IVD industry as he held different positions in sales for Roche Diagnostics France from 2000 to 2006 and afterwards in Marketing for Dade-Behring. From 2008 to 2020, he worked for Siemens Healthcare Diagnostics France, Sales and Marketing departments before becoming the Managing Director from 2014 to 2020. As a board member of SIDIV, Jean-Philippe is an actor in the definition of its strategy and the execution of its operational roadmap. He is, in particular, in charge of piloting the External Communication and HR Working Groups. In addition to his deep knowledge and expertise of the IVD sector, Jean-Philippe is a doctor in Pharmacy and PhD in biology from the University of Paris, France.

Bernard Colombo joined Roche in 2008 during the integration of Ventana Medical Systems. At Ventana, he had held various positions in Marketing, Sales and Support and, since 2006, assumed central responsibility for developing the company’s business in EMEA as Vice President and General Manager of Ventana Medical Systems. From 2008 to 2010, he spearheaded the acceleration and integration of the RTD (Roche Tissue Diagnostics) business for EMEA-LATAM. He was appointed Head of the EMEA Subregion North-West in the Diagnostics Division in 2010, based in Rotkreuz, Switzerland. In 2017, he was appointed General Manager for Roche Diagnostics France Management Centre, where he was responsible for the French Domestic, Maghreb and French Speaking Sub-Saharan African markets, before assuming his current position as Regional Head Roche Diagnostics EMEA/LATAM in November 2018. Bernard has extensive experience in the healthcare industry, particularly in Diagnostics, where he has worked for 34 years, having started at Boehringer Mannheim in 1984 and including 10 years at Bayer Diagnostics. He has lived and worked in France and Switzerland, and holds a Master’s degree in Biomedical Engineering from Claude Bernard Lyon 1 University in France.

Daniela Delledonne serves as Vice-President & General Manager BD Biosciences EMEA. She joined BD in 2014 and for seven years she was General Manager for Italy & Greece. She is a member of the BD EMEA Leadership Team. Daniela Delledonne prior to BD worked three years for Hill-Rom as Managing Director in Italy, twelve years for Medtronic leading various business units at country level and leading strategic projects at international level, three years for Sorin Biomedical Cardio as global upstream product manager and two years in Covidien in sales. Daniela has been twice chairman of Medical Device Trade Association Assobiomedica, and most recently for 2 years she held the position of Vice President Strategies and Market Development at Confindustria Dispositivi Medici. Daniela holds an Executive diploma from the Wharton Business School of Philadelphia, a diploma in Leadership from the Glasgow Caledonian University, a Master in Business Management from Cattolica University of Milan & ISTUD Business School, and a “best honors degree” in Chemistry and Pharmaceutical Technologies from Parma University.

Bill Doherty is a long-serving board member and former chair of the Irish Medtech Association. He currently chairs the IMA’s Code of Ethics Committee and leads its PR Taskforce. Bill served on the board of Eucomed during its merger with EDMA to form Medtech Europe and is currently a member of the Code Taskforce (Hypercare Team) established by Medtech Europe’s board to advise on Code implementation. Bill believes in the importance of national association participation at European level and has encouraged the Irish Medtech Association to become highly engaged with Medtech Europe through the different working groups. At national level, the Irish Medtech Association has been a key catalyst in fostering a vibrant medtech environment in Ireland directly employing 38,000 people, which is the highest per-capita in the EU and 6th largest in terms of absolute employment numbers. Medtech is a key pillar of Ireland’s economy accounting for 11% of total exports. Bill is Executive Vice President EMEA with Cook Medical and a member of the executive board of the parent company, and also sits on its Board Risk and Oversight Committee. Since joining Cook Medical in 1994 he has led and overseen significant structural and operational changes to its EMEA business. Bill is a strong advocate for transparency, sustainability and ethics in business and sponsors Cook Medical’s global CSR Programme.

Rika Dutau is Vice President & General Manager  Commercial Operations for the Europe, Middle East and Africa regions. She joined Cepheid in 2007, being before VP and General Manager at Teleflex where she was heading the Surgical Business across Europe, the Middle-East and Africa. Previously, she held a variety of senior management roles, including responsibilities in Commercial Operations, Marketing, Sales and Business Development in the medical device and critical care industry. Rika holds a Pharmacist degree (M.Sc.Pharm.) from the University of Ghent, Belgium. She lives in Toulouse, France.

Cristiano Franzi joined Baxter in 2017 from Medtronic plc, where he served as vice president and president, Minimally Invasive Therapies Group EMEA from 2015 to 2017. He served as President EMEA at Covidien plc prior to Medtronic’s acquisition of Covidien. He served as member of the board of Eucomed Medical Technology from 2013 to 2015. Cristiano completed the Advanced Management Program (AMP197) at Harvard Business School, holds an MBA from George Washington University and a bachelor’s degree in Marketing from the American University.

CEO for Medicoindustrien for the last 10 years.

Bachelor of Biology (University of Barcelona). Master in Alimentary Biotechnology for ETSIB (Superior Technical School of Engineers from Barcelona), Executive MBA for INESE and Superior Course of Organization and commercial Direction for the Chamber of Trade of Madrid. During lasts years Carlos has occupied positions of responsibility in marketing and sales as well as commercial management in several divisions in different companies of the sector of sanitary technology (Product Manager in Roche Diagnostics S.L., Business Unit Manager in Bayer Diagnostics S.L., Division Check Up Manager in Menarini Diagnostics S.L and Sales and Marketing Manager in Dade Behring S.A.) He is married with three children. Carlos joined FENIN 17 years ago as Director of the Barcelona office along and Secretary of IVD Sector and Secretary of Technology and Clinical Information Systems Sector

Alexander “Alex” Socarrás is Executive Vice President (EVP) and Head of Siemens Healthineers Diagnostics in Europe, Middle East and Africa (EMEA). He has been a member of MedTech Europe’s Board since December 2021 and is a key member of Siemens Healthineers’ Global Leadership team. He is passionate about access to care, and a strong believer in the value of diversity, equity, and inclusion, as well as the idea that people and culture are strategic differentiators. Alex has over 30 years of experience within the healthcare industry, specializing in in vitro diagnostics (IVD) and life sciences, with a diverse background leading teams in multiple global geographies including North America, Latin America, EMEA, China, Asia-Pacific, and Japan. Prior to becoming Head of EMEA for Siemens Healthineers Diagnostics, Alex served as EVP and Chief Commercial Officer at Ortho Clinical Diagnostics, where he managed the carve-out, global standup, and return to performance of Ortho under private equity ownership. Prior to Ortho, Alex was Senior Vice President and General Manager of Siemens Healthcare’s Southwest Europe Region, leading its Imaging & IT, Clinical Products, and Diagnostics businesses, after successfully integrating the company’s Diagnostics Division in Latin America. Alex has also worked for Bayer, Roche, and Baxter in North America with numerous roles in R&D, sales, marketing, and services. He holds a Bachelor of Science degree in Chemistry with a minor in Mathematics from the University of Miami, and a Master of Business Administration (with Honors) from Nova Southeastern University.  His is fluent in English, Spanish and Portuguese.

Dr. Martin Walger is managing director of the German IVD Association VDGH , representing 100 members  companies (IVD- and Life Science Research Industry).  He joined VDGH in 2008. From 1995 to 2008 Martin Walger has been serving as director Personnel and Hospital organization for the German Hospital Federation DKG.  From 1993 to 1995 he worked for the Bundesknappschaft, part of the German  statutory health insurance. Previously he did research at the Center for Labour and Social issues (ZENTRAS). He is holding a degree in economics from the University of Trier, Germany. Born in 1962, Martin Walger is married with three children.

Gavin Wood is Company Group Chairman, Johnson & Johnson Medical Devices EMEA. He is responsible for guiding our business efforts in both mature and emerging markets throughout the region, overseeing the medical devices franchises in the region. Previously, Gavin served as Worldwide President, Ethicon Wound Closure & Healing, leading the global team and upholding the legacy of our market-leading wound closure portfolio while guiding the evolution of the business into the surgical tissue healing space.  He also has held roles as Executive Vice President, Commercial at Mölnlycke, a medical device company focused on advancing performance in Wound Management and Surgical Solutions. He also held the roles of Global Vice President, Strategic Marketing, and Vice President Corporate Strategy & Business Development for Mölnlycke. Before joining Mölnlycke, Gavin held multiple International roles over more than a decade at Johnson & Johnson across our Medical Devices business. He served as Managing Director for Central & Eastern Europe and GM, Global Surgery for Czech Republic and Slovakia. Other leadership roles with J&J included Strategy and New Business Development Director for Emerging Markets, EMEA and other functions including Marketing, Market Access and Sales. Gavin holds a Bachelor of Arts degree in Law from Carleton University, Canada, and an MBA from Queen’s University, Canada. He is Canadian by origin, and has lived in Germany, the Czech Republic, Sweden and the United States.